Teriparatide (PTH 1-34) studies: 484 papers with results
Page 3 of 10
- Two-year clinical outcome of denosumab treatment alone and in combination with teriparatide in Japanese treatment-naive postmenopausal osteoporotic women.
Nakamura Y · Bone research · 2017
Randomized controlled trial · 5 results
- The efficacy of teriparatide (Cinnopar®) on bone repair in mandibular fractures: A single blinded randomized clinical trial.
Ebrahimi S · Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery · 2022
Randomized controlled trial · 2 results
- Changes in serum fibroblast growth factor 2 in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34).
Hurley M · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2005
Randomized controlled trial · 3 results
- PTH(1-34) for the Primary Prevention of Postthyroidectomy Hypocalcemia: The THYPOS Trial.
Palermo A · The Journal of clinical endocrinology and metabolism · 2016
Randomized controlled trial · 5 results
- Effect of teriparatide on early bone loss after kidney transplantation.
Cejka D · American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2008
Randomized controlled trial · 6 results
- Relative bioavailability between two teriparatide formulations in healthy volunteers.
Farías J · International journal of clinical pharmacology and therapeutics · 2016
Randomized controlled trial · 7 results
- Short-term teriparatide delivery and osseointegration: a clinical feasibility study.
Kuchler U · Journal of dental research · 2011
Randomized controlled trial · 6 results
- Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized, controlled trial.
Anastasilakis AD · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2008
Randomized controlled trial · 2 results
- Effects of Teriparatide and Vibration on Bone Mass and Bone Strength in People with Bone Loss and Spinal Cord Injury: A Randomized, Controlled Trial.
Edwards WB · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018
Randomized controlled trial · 9 results
- May etanercept and PTH (1-34) association heal erosions in early rheumatoid arthritis? A pilot study.
Migliore A · European review for medical and pharmacological sciences · 2012
Randomized controlled trial · 5 results
- The combined effect of Parathyroid hormone (1-34) and whole-body Vibration exercise in the treatment of postmenopausal OSteoporosis (PaVOS study): a randomized controlled trial.
Jepsen DB · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2019
Randomized controlled trial · 4 results
- Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters.
Arlot M · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2005
Randomized controlled trial · 10 results
- Daily subcutaneous Teriparatide injection increased bone mineral density of newly formed bone after tibia distraction osteogenesis, a randomized study.
Wagner F · Injury · 2019
Randomized controlled trial · 1 result
- Topical PTH (1-34) is a novel, safe and effective treatment for psoriasis: a randomized self-controlled trial and an open trial.
Holick MF · The British journal of dermatology · 2003
Randomized controlled trial · 9 results
- Teriparatide has no effect on the calcium-mediated pharmacodynamics of digoxin.
Benson CT · Clinical pharmacology and therapeutics · 2003
Randomized controlled trial · 1 result
- Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism.
Winer KK · The Journal of clinical endocrinology and metabolism · 2008
Randomized controlled trial · 5 results
- Short-term effects of teriparatide versus placebo on bone biomarkers, structure, and fracture healing in women with lower-extremity stress fractures: A pilot study.
Almirol EA · Journal of clinical & translational endocrinology · 2016
Randomized controlled trial · 9 results
- Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.
Winer KK · JAMA · 1996
Randomized controlled trial · 3 results
- Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans.
Fraher LJ · The Journal of clinical endocrinology and metabolism · 1995
Randomized controlled trial · 8 results
- Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
Neer RM · The New England journal of medicine · 2001
Randomized controlled trial · 12 results
- The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.
Orwoll ES · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2003
Randomized controlled trial · 14 results
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial.
Tsai JN · Lancet (London, England) · 2013
Randomized controlled trial · 9 results
- Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis.
Lindsay R · Archives of internal medicine · 2004
Randomized controlled trial · 5 results
- Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis.
Finkelstein JS · The Journal of clinical endocrinology and metabolism · 2010
Randomized controlled trial · 10 results
- Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial.
Leder BZ · The Journal of clinical endocrinology and metabolism · 2014
Randomized controlled trial · 11 results
- Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.
Miller PD · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2007
Randomized controlled trial · 14 results
- Role of Weekly Teriparatide Administration in Osseous Union Enhancement within Six Months After Posterior or Transforaminal Lumbar Interbody Fusion for Osteoporosis-Associated Lumbar Degenerative Disorders: A Multicenter, Prospective Randomized Study.
Ebata S · The Journal of bone and joint surgery. American volume · 2017
Randomized controlled trial · 2 results
- Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phases.
Miyauchi A · Bone · 2010
Randomized controlled trial · 16 results
- A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism.
Winer KK · The Journal of clinical endocrinology and metabolism · 1998
Randomized controlled trial · 8 results
- Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass.
Genant HK · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017
Randomized controlled trial · 11 results
- Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study).
Tsai JN · The Journal of clinical endocrinology and metabolism · 2016
Randomized controlled trial · 16 results
- The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1.
Gatti D · The Journal of clinical endocrinology and metabolism · 2011
Randomized controlled trial · 9 results
- Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass.
Keaveny TM · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017
Randomized controlled trial · 2 results
- Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene.
Cosman F · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2013
Randomized controlled trial · 14 results
- Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34).
Buxton EC · The Journal of clinical endocrinology and metabolism · 2004
Randomized controlled trial · 4 results
- Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral density.
Muschitz C · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2013
Randomized controlled trial · 15 results
- Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.
Devogelaer JP · The Journal of rheumatology · 2010
Randomized controlled trial · 4 results
- Teriparatide Versus Alendronate for the Preservation of Bone Mineral Density After Total Hip Arthroplasty - A randomized Controlled Trial.
Kobayashi N · The Journal of arthroplasty · 2016
Randomized controlled trial · 3 results
- Influences of teriparatide administration on marrow fat content in postmenopausal osteopenic women using MR spectroscopy.
Yang Y · Climacteric : the journal of the International Menopause Society · 2016
Randomized controlled trial · 8 results
- Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women.
Shiraki M · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2013
Randomized controlled trial · 10 results
- Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a Randomized Controlled Trial.
Tsai JN · Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry · 2017
Randomized controlled trial · 13 results
- Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
Eastell R · Bone · 2010
Randomized controlled trial · 4 results
- Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled Trial.
Leder BZ · Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry · 2016
Randomized controlled trial · 10 results
- Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
Bouxsein ML · The Journal of bone and joint surgery. American volume · 2009
Randomized controlled trial · 3 results
- Effects of teriparatide in Japanese and non-Japanese populations: bridging findings on pharmacokinetics and efficacy.
Tsujimoto M · Journal of bone and mineral metabolism · 2012
Randomized controlled trial · 9 results
- Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 study.
Tripto-Shkolnik L · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
Randomized controlled trial · 10 results
- Serum Sclerostin Levels in Adults With Osteogenesis Imperfecta: Comparison With Normal Individuals and Response to Teriparatide Therapy.
Nicol L · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018
Randomized controlled trial · 3 results
- Effects of teriparatide and loading modality on modeling-based and remodeling-based bone formation in the human femoral neck.
Rooney AM · Bone · 2022
Randomized controlled trial · 6 results
- Safety Profiles, Pharmacokinetics, and Changes in Bone Turnover Markers After Twice-Weekly Subcutaneous Administration of Teriparatide in Healthy Japanese Postmenopausal Women: A Single-Blind Randomized Study.
Kumagai Y · Clinical pharmacology in drug development · 2020
Randomized controlled trial · 7 results
- Distribution of Prevalent and Incident Vertebral Fractures and Their Association with Bone Mineral Density in Postmenopausal Women in the Teriparatide Versus Risedronate VERO Clinical Trial.
Geusens P · Calcified tissue international · 2020
Randomized controlled trial · 5 results